# TACLONEX
> **NDA022185** · New Drug Application · Sponsor: LEO PHARMA AS · Approved 2008-05-09
## Drug
- **FDA Application Number:** NDA022185
- **Application type:** New Drug Application
- **Brand name:** TACLONEX
- **Generic name:** CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
- **Active ingredients:** BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
- **Dosage form:** SUSPENSION
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** LEO PHARMA AS
- **Manufacturer:** LEO Pharma Inc.
- **First approval:** 2008-05-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022185)
---
*AI Analytics · CC0 1.0*